Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study (iMACS)

This study has been completed.
Sponsor:
Collaborator:
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Wafaa Mahmoud El-Sadr, Columbia University
ClinicalTrials.gov Identifier:
NCT02027480
First received: January 2, 2014
Last updated: December 22, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)